세계의 여성 스트레스성 요실금 치료 시장 : 산업 분석, 규모, 점유율, 성장, 동향 예측(2024-2031년)

Persistence Market Research has recently published an in-depth report on the global Female Stress Urinary Incontinence (SUI) Treatment Devices Market, providing a detailed analysis of key market dynamics, including growth drivers, trends, opportunities, and challenges. This comprehensive report offers insights into the market landscape, aiding stakeholders in making well-informed decisions.

Key Insights:

• Female SUI Treatment Devices Market Size (2024E): US$764.2 Mn
• Projected Market Value (2031F): US$1187.3 Mn
• Global Market Growth Rate (CAGR 2024 to 2031): 6.5%

Female Stress Urinary Incontinence Treatment Devices Market - Report Scope:

The Female Stress Urinary Incontinence (SUI) Treatment Devices Market includes a variety of medical devices aimed at addressing urinary leakage caused by weakened pelvic muscles. These devices include slings, artificial urinary sphincters, and other advanced solutions designed to restore bladder control. The market growth is driven by increasing awareness about SUI, growing demand for minimally invasive treatments, and technological advancements in treatment devices. The rising prevalence of SUI among women, especially post-menopausal women, further fuels demand for these medical devices.

Market Growth Drivers:

Several key factors drive the growth of the global Female SUI Treatment Devices Market. These include the growing incidence of stress urinary incontinence due to aging, childbirth, and obesity, which increase the need for effective treatment options. Rising awareness among women about treatment solutions and the availability of advanced, minimally invasive procedures are boosting the market. Government initiatives to improve women's health, coupled with increasing healthcare expenditure, are also key growth drivers. Additionally, ongoing research and development efforts to enhance device efficiency and patient outcomes are fostering market expansion.

Market Restraints:

The Female SUI Treatment Devices Market faces several challenges, including the high cost of advanced treatment devices, which may limit adoption, particularly in developing regions. Invasive procedures, potential complications, and the risk of device failure or revision surgery may deter some patients from opting for these treatments. Moreover, a lack of awareness in certain regions and cultural stigmas surrounding urinary incontinence could further restrict market growth. Addressing these barriers requires efforts in education, cost reduction, and improving accessibility to advanced treatments.

Market Opportunities:

The Female SUI Treatment Devices Market presents substantial growth opportunities driven by rising demand for non-invasive and less painful treatment options. Advances in healthcare technology, such as the development of robotic-assisted devices and innovations in sling materials, offer potential for significant market growth. Expansion into emerging markets with improving healthcare infrastructure, coupled with strategic partnerships between manufacturers and healthcare providers, will create new opportunities. Moreover, the increasing focus on patient-centric care and improving the quality of life for SUI patients will likely drive further adoption of these treatment devices.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the global Female SUI Treatment Devices Market?
• Which regions are leading in the adoption of stress urinary incontinence treatment devices?
• How are technological advancements impacting the market landscape for SUI treatment devices?
• Who are the major players in the Female SUI Treatment Devices Market, and what strategies are they adopting to stay competitive?
• What are the emerging trends and future prospects for the global Female SUI Treatment Devices Market?

Competitive Intelligence and Business Strategy:

Leading companies in the Female SUI Treatment Devices Market, such as Boston Scientific Corporation, Medtronic, and Coloplast Group, are focusing on innovation, product development, and strategic collaborations to maintain a competitive edge. These companies are investing in advanced treatment technologies, enhancing device functionality, and improving patient outcomes. Collaborations with healthcare professionals, hospitals, and academic institutions are essential for product development and market penetration. Expanding distribution networks and ensuring regulatory compliance with stringent medical device standards are crucial strategies for growth in this market.

Key Companies Profiled:

• Boston Scientific Corporation
• Coloplast Group
• Medtronic
• Ethicon (Johnson & Johnson)
• Caldera Medical
• C. R. Bard (Becton, Dickinson and Company)
• Promedon Group
• Zephyr Surgical Implants
• Cogentix Medical
• T. J. Smith & Nephew

Female Stress Urinary Incontinence Treatment Devices Industry Research by Category:

By Product Type

• Urethral Slings
• Catheters
• Vaginal Pessaries

By End User

• Hospitals
• Specialty Clinics

By Region:

• North America
• Europe
• East Asia
• South Asia
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Female Stress Urinary Incontinence Treatment Devices Market Snapshot, 2024-2031
• 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global Sectorial Outlook
  • 2.3.2. Global GDP Growth Outlook
  • 2.3.3. Global Healthcare Spending Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Product Adoption Analysis
• 3.2. Technology Assessment
• 3.3. Regulatory Scenario
• 3.4. Value Chain Analysis
  • 3.4.1. List of Distribution Channel/Marketplaces
    • 3.4.1.1. Retail
    • 3.4.1.2. E-Commerce
  • 3.4.2. List of End User (Industry)
• 3.5. Key Deals and Mergers
• 3.6. PESTLE Analysis
• 3.7. Porter's Five Force Analysis

4. Price Trend Analysis, 2019-2031

• 4.1. Key Highlights
• 4.2. Key Factors Impacting Product Prices
• 4.3. Pricing Analysis, By Product
• 4.4. Regional Prices and Product Preferences

5. Global Female Stress Urinary Incontinence Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 5.1. Key Highlights
  • 5.1.1. Market Volume (Units) Projections
  • 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
  • 5.1.3. Absolute $ Opportunity
• 5.2. Market Size (US$ Mn) Analysis and Forecast
  • 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2023
  • 5.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2024-2031
• 5.3. Global Female Stress Urinary Incontinence Treatment Devices Market Outlook: Product Type
  • 5.3.1. Introduction / Key Findings
  • 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product Type, 2019-2023
  • 5.3.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2024-2031
    • 5.3.3.1. Urethral Slings
    • 5.3.3.2. Catheters
    • 5.3.3.3. Vaginal Pessaries
• 5.4. Market Attractiveness Analysis: Product Type
• 5.5. Global Female Stress Urinary Incontinence Treatment Devices Market Outlook: End-user
  • 5.5.1. Introduction / Key Findings
  • 5.5.2. Historical Market Size (US$ Mn) Analysis, By End-user, 2019-2023
  • 5.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2024-2031
    • 5.5.3.1. Hospitals
    • 5.5.3.2. Specialty Clinics
• 5.6. Market Attractiveness Analysis: End-user

6. Global Female Stress Urinary Incontinence Treatment Devices Market Outlook: Region

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Region, 2019-2023
• 6.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2024-2031
  • 6.3.1. North America
  • 6.3.2. Europe
  • 6.3.3. East Asia
  • 6.3.4. South Asia and Oceania
  • 6.3.5. Latin America
  • 6.3.6. Middle East & Africa
• 6.4. Market Attractiveness Analysis: Region

7. North America Female Stress Urinary Incontinence Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 7.1. Key Highlights
• 7.2. Pricing Analysis
• 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market, 2019-2023
  • 7.3.1. By Country
  • 7.3.2. By Product Type
  • 7.3.3. By End-user
• 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
  • 7.4.1. U.S.
  • 7.4.2. Canada
• 7.5. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2024-2031
  • 7.5.1. Urethral Slings
  • 7.5.2. Catheters
  • 7.5.3. Vaginal Pessaries
• 7.6. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By End-user, 2024-2031
  • 7.6.1. Hospitals
  • 7.6.2. Specialty Clinics
• 7.7. Market Attractiveness Analysis

8. Europe Female Stress Urinary Incontinence Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 8.1. Key Highlights
• 8.2. Pricing Analysis
• 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market, 2019-2023
  • 8.3.1. By Country
  • 8.3.2. By Product Type
  • 8.3.3. By End-user
• 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. U.K.
  • 8.4.4. Italy
  • 8.4.5. Spain
  • 8.4.6. Russia
  • 8.4.7. Turkiye
  • 8.4.8. Rest of Europe
• 8.5. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2024-2031
  • 8.5.1. Urethral Slings
  • 8.5.2. Catheters
  • 8.5.3. Vaginal Pessaries
• 8.6. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By End-user, 2024-2031
  • 8.6.1. Hospitals
  • 8.6.2. Specialty Clinics
• 8.7. Market Attractiveness Analysis

9. East Asia Female Stress Urinary Incontinence Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 9.1. Key Highlights
• 9.2. Pricing Analysis
• 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market, 2019-2023
  • 9.3.1. By Country
  • 9.3.2. By Product Type
  • 9.3.3. By End-user
• 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
  • 9.4.1. China
  • 9.4.2. Japan
  • 9.4.3. South Korea
• 9.5. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2024-2031
  • 9.5.1. Urethral Slings
  • 9.5.2. Catheters
  • 9.5.3. Vaginal Pessaries
• 9.6. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By End-user, 2024-2031
  • 9.6.1. Hospitals
  • 9.6.2. Specialty Clinics
• 9.7. Market Attractiveness Analysis

10. South Asia & Oceania Female Stress Urinary Incontinence Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 10.1. Key Highlights
• 10.2. Pricing Analysis
• 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market, 2019-2023
  • 10.3.1. By Country
  • 10.3.2. By Product Type
  • 10.3.3. By End-user
• 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
  • 10.4.1. India
  • 10.4.2. Southeast Asia
  • 10.4.3. ANZ
  • 10.4.4. Rest of South Asia & Oceania
• 10.5. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2024-2031
  • 10.5.1. Urethral Slings
  • 10.5.2. Catheters
  • 10.5.3. Vaginal Pessaries
• 10.6. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By End-user, 2024-2031
  • 10.6.1. Hospitals
  • 10.6.2. Specialty Clinics
• 10.7. Market Attractiveness Analysis

11. Latin America Female Stress Urinary Incontinence Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 11.1. Key Highlights
• 11.2. Pricing Analysis
• 11.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market, 2019-2023
  • 11.3.1. By Country
  • 11.3.2. By Product Type
  • 11.3.3. By End-user
• 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
  • 11.4.1. Brazil
  • 11.4.2. Mexico
  • 11.4.3. Rest of Latin America
• 11.5. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2024-2031
  • 11.5.1. Urethral Slings
  • 11.5.2. Catheters
  • 11.5.3. Vaginal Pessaries
• 11.6. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By End-user, 2024-2031
  • 11.6.1. Hospitals
  • 11.6.2. Specialty Clinics
• 11.7. Market Attractiveness Analysis

12. Middle East & Africa Female Stress Urinary Incontinence Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 12.1. Key Highlights
• 12.2. Pricing Analysis
• 12.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market, 2019-2023
  • 12.3.1. By Country
  • 12.3.2. By Product Type
  • 12.3.3. By End-user
• 12.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
  • 12.4.1. GCC Countries
  • 12.4.2. Egypt
  • 12.4.3. South Africa
  • 12.4.4. Northern Africa
  • 12.4.5. Rest of Middle East & Africa
• 12.5. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2024-2031
  • 12.5.1. Urethral Slings
  • 12.5.2. Catheters
  • 12.5.3. Vaginal Pessaries
• 12.6. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By End-user, 2024-2031
  • 12.6.1. Hospitals
  • 12.6.2. Specialty Clinics
• 12.7. Market Attractiveness Analysis

13. Competition Landscape

• 13.1. Market Share Analysis, 2024
• 13.2. Market Structure
  • 13.2.1. Competition Intensity Mapping By Market
  • 13.2.2. Competition Dashboard
• 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 13.3.1. Boston Scientific Corporation
    • 13.3.1.1. Overview
    • 13.3.1.2. Segments and Product Types
    • 13.3.1.3. Key Financials
    • 13.3.1.4. Market Developments
    • 13.3.1.5. Market Strategy
  • 13.3.2. Johnson & Johnson Services Inc.
  • 13.3.3. BD
  • 13.3.4. Coloplast A/S
  • 13.3.5. CooperSurgical Inc.
  • 13.3.6. MEDGYN PRODUCTS Inc.
  • 13.3.7. Cousin Biotech
  • 13.3.8. Caldera Medical
  • 13.3.9. Betatech Medical
  • 13.3.10. FEG Textiltechnik mbH
  • 13.3.11. C.R. Bard

14. Appendix

• 14.1. Research Methodology
• 14.2. Research Assumptions
• 14.3. Acronyms and Abbreviations